News list for " market license"

Wantai Bio: The company's application for marketing authorization for nine-valent HPV vaccine was accepted

On August 26th, Wantai Bio announced in the evening that the application for marketing authorization of the nine-valent HPV vaccine jointly developed by Wantai Canghai, a wholly-owned subsidiary of the company, and Xiamen University has been accepted by the Drug Evaluation Center of the State Food and Drug Administration. According to the "Drug Registration Administration Measures", the State Food and Drug Administration will conduct a technical review of the safety, efficacy and quality control...

clock
2024-08-26 07:58:17
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.